UBS Group’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
42,134
+34,916
+484% +$1.13M ﹤0.01% 5350
2025
Q4
$251K Sell
7,218
-34,016
-82% -$1.2M ﹤0.01% 6462
2025
Q3
$1.5M Buy
41,234
+18,682
+83% +$635K ﹤0.01% 5235
2025
Q2
$708K Sell
22,552
-153,580
-87% -$4.77M ﹤0.01% 5732
2025
Q1
$5.23M Buy
176,132
+35,426
+25% +$1.06M ﹤0.01% 3737
2024
Q4
$4.15M Buy
140,706
+96,987
+222% +$3.07M ﹤0.01% 4028
2024
Q3
$1.36M Buy
43,719
+30,520
+231% +$1.11M ﹤0.01% 4357
2024
Q2
$447K Sell
13,199
-81
-0.6% -$4.13K ﹤0.01% 5080
2024
Q1
$863K Buy
13,280
+11,971
+915% +$822K ﹤0.01% 4719
2023
Q4
$89.4K Sell
1,309
-169
-11% -$8.78K ﹤0.01% 6233
2023
Q3
$76.7K Sell
1,478
-398
-21% -$23.6K ﹤0.01% 6015
2023
Q2
$112K Buy
1,876
+221
+13% +$12.6K ﹤0.01% 5910
2023
Q1
$81.8K Sell
1,655
-4,894
-75% -$275K ﹤0.01% 6079
2022
Q4
$374K Buy
6,549
+627
+11% +$35.3K ﹤0.01% 4947
2022
Q3
$278K Sell
5,922
-1,174
-17% -$55.9K ﹤0.01% 4830
2022
Q2
$265K Sell
7,096
-1,312
-16% -$42.6K ﹤0.01% 4708
2022
Q1
$251K Sell
8,408
-1,037
-11% -$26.2K ﹤0.01% 5187
2021
Q4
$323K Sell
9,445
-4,556
-33% -$165K ﹤0.01% 5316
2021
Q3
$519K Buy
14,001
+1,987
+17% +$67.1K ﹤0.01% 4709
2021
Q2
$469K Buy
12,014
+341
+3% +$13.2K ﹤0.01% 4776
2021
Q1
$497K Buy
+11,673
New +$520K ﹤0.01% 4871

Other funds holding IMCR